Compile Data Set for Download or QSAR
Report error Found 52 Enz. Inhib. hit(s) with all data for entry = 8350
TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242568(US9422240, 1-378)
Affinity DataIC50: 14nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242567(US9422240, 1-377)
Affinity DataIC50: 15nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242554(US9422240, 1-296)
Affinity DataIC50: 15nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242526(US9422240, 1-4)
Affinity DataIC50: 19nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242563(US9422240, 1-366)
Affinity DataIC50: 19nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242577(US9422240, 1-443)
Affinity DataIC50: 21nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242566(US9422240, 1-376)
Affinity DataIC50: 22nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242535(US9422240, 1-254)
Affinity DataIC50: 24nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242542(US9422240, 1-355 | US9422240, 1-265)
Affinity DataIC50: 24nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242575(US9422240, 1-409)
Affinity DataIC50: 25nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242564(US9422240, 1-367)
Affinity DataIC50: 26nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242571(US9422240, 1-392)
Affinity DataIC50: 26nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242572(US9422240, 1-393)
Affinity DataIC50: 32nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242576(US9422240, 1-440)
Affinity DataIC50: 39nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242528(US9422240, 1-70)
Affinity DataIC50: 39nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242532(US9422240, 1-225)
Affinity DataIC50: 40nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242548(US9422240, 1-284)
Affinity DataIC50: 40nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242565(US9422240, 1-368)
Affinity DataIC50: 41nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242558(US9422240, 1-353)
Affinity DataIC50: 43nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242549(US9422240, 1-285)
Affinity DataIC50: 43nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242551(US9422240, 1-287)
Affinity DataIC50: 45nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242570(US9422240, 1-386)
Affinity DataIC50: 48nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242531(US9422240, 1-209)
Affinity DataIC50: 49nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242542(US9422240, 1-355 | US9422240, 1-265)
Affinity DataIC50: 52nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242569(US9422240, 1-385)
Affinity DataIC50: 54nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242573(US9422240, 1-404)
Affinity DataIC50: 56nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242562(US9422240, 1-365)
Affinity DataIC50: 56nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242530(US9422240, 1-205)
Affinity DataIC50: 59nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242561(US9422240, 1-356)
Affinity DataIC50: 60nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242559(US9422240, 1-354)
Affinity DataIC50: 61nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242550(US9422240, 1-286)
Affinity DataIC50: 61nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242547(US9422240, 1-283)
Affinity DataIC50: 63nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242539(US9422240, 1-258)
Affinity DataIC50: 63nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242537(US9422240, 1-256)
Affinity DataIC50: 66nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242536(US9422240, 1-255)
Affinity DataIC50: 66nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242553(US9422240, 1-289)
Affinity DataIC50: 68nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242541(US9422240, 1-260)
Affinity DataIC50: 69nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242574(US9422240, 1-408)
Affinity DataIC50: 72nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242538(US9422240, 1-257)
Affinity DataIC50: 75nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242546(US9422240, 1-282)
Affinity DataIC50: 77nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242556(US9422240, 1-298)
Affinity DataIC50: 79nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242534(US9422240, 1-252)
Affinity DataIC50: 87nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242527(US9422240, 1-28)
Affinity DataIC50: 88nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242555(US9422240, 1-297)
Affinity DataIC50: 89nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242557(US9422240, 1-333)
Affinity DataIC50: 92nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242529(US9422240, 1-72)
Affinity DataIC50: 94nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242540(US9422240, 1-259)
Affinity DataIC50: 96nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242545(US9422240, 1-275)
Affinity DataIC50: 99nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242544(US9422240, 1-274)
Affinity DataIC50: 108nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Taisho Pharmaceutical

US Patent
LigandPNGBDBM242543(US9422240, 1-273)
Affinity DataIC50: 112nMpH: 7.5Assay Description:The enzyme and the substrate were each diluted with a 50 mM tris-hydrochloric acid buffer (pH 7.5) containing 12.5 mM KCl, 3.75 mM MgCl2, 25 μM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
Go to US Patent

Displayed 1 to 50 (of 52 total ) | Next | Last >>
Jump to: